Personal history of psoriasis and risk of incident cancer among women: a population-based cohort study
W-Q. Li
Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, RI, U.S.A.
Department of Epidemiology, School of Public Health, Brown University, Providence, RI, U.S.A.
Search for more papers by this authorJ. Han
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, U.S.A.
Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN, U.S.A.
Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN, U.S.A.
Search for more papers by this authorE. Cho
Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, RI, U.S.A.
Department of Epidemiology, School of Public Health, Brown University, Providence, RI, U.S.A.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, U.S.A.
Search for more papers by this authorS. Wu
Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, RI, U.S.A.
Search for more papers by this authorH. Dai
Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN, U.S.A.
Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN, U.S.A.
Search for more papers by this authorM.A. Weinstock
Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, RI, U.S.A.
Department of Epidemiology, School of Public Health, Brown University, Providence, RI, U.S.A.
Center for Dermatoepidemiology, VA Medical Center, Providence, RI, U.S.A.
Department of Dermatology, Rhode Island Hospital, Providence, RI, U.S.A.
Search for more papers by this authorA.A. Qureshi
Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, RI, U.S.A.
Department of Epidemiology, School of Public Health, Brown University, Providence, RI, U.S.A.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, U.S.A.
Department of Dermatology, Rhode Island Hospital, Providence, RI, U.S.A.
Search for more papers by this authorW-Q. Li
Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, RI, U.S.A.
Department of Epidemiology, School of Public Health, Brown University, Providence, RI, U.S.A.
Search for more papers by this authorJ. Han
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, U.S.A.
Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN, U.S.A.
Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN, U.S.A.
Search for more papers by this authorE. Cho
Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, RI, U.S.A.
Department of Epidemiology, School of Public Health, Brown University, Providence, RI, U.S.A.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, U.S.A.
Search for more papers by this authorS. Wu
Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, RI, U.S.A.
Search for more papers by this authorH. Dai
Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN, U.S.A.
Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN, U.S.A.
Search for more papers by this authorM.A. Weinstock
Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, RI, U.S.A.
Department of Epidemiology, School of Public Health, Brown University, Providence, RI, U.S.A.
Center for Dermatoepidemiology, VA Medical Center, Providence, RI, U.S.A.
Department of Dermatology, Rhode Island Hospital, Providence, RI, U.S.A.
Search for more papers by this authorA.A. Qureshi
Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, RI, U.S.A.
Department of Epidemiology, School of Public Health, Brown University, Providence, RI, U.S.A.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, U.S.A.
Department of Dermatology, Rhode Island Hospital, Providence, RI, U.S.A.
Search for more papers by this author
Supporting Information
| Filename | Description |
|---|---|
| bjd14301-sup-0001-SupInfo.docWord document, 242 KB | Appendix S1. Supplementary methods, results, discussion and references. Figure S1. Flow diagram of inclusion/exclusion of participants. Table S1. Age-standardized characteristics of the study population by psoriasis status in 1996 (n = 64 990). |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007; 445: 866–73.
- 2Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol 2014; 15: e493–503.
- 3Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646–74.
- 4Li W, Han J, Choi HK, Qureshi AA. Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis. Am J Epidemiol 2012; 175: 402–13.
- 5Dominguez PL, Assarpour A, Kuo H et al. Development and pilot-testing of a psoriasis screening tool. Br J Dermatol 2009; 161: 778–84.
- 6Gelfand JM, Shin DB, Neimann AL et al. The risk of lymphoma in patients with psoriasis. J Invest Dermatol 2006; 126: 2194–201.
- 7Margolis D, Bilker W, Hennessy S et al. The risk of malignancy associated with psoriasis. Arch Dermatol 2001; 137: 778–83.
- 8Brauchli YB, Jick SS, Miret M, Meier CR. Psoriasis and risk of incident cancer: an inception cohort study with a nested case–control analysis. J Invest Dermatol 2009; 129: 2604–12.
- 9Chen YJ, Wu CY, Chen TJ et al. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan. J Am Acad Dermatol 2011; 65: 84–91.
- 10Lee MS, Lin RY, Chang YT, Lai MS. The risk of developing non-melanoma skin cancer, lymphoma and melanoma in patients with psoriasis in Taiwan: a 10-year, population-based cohort study. Int J Dermatol 2012; 51: 1454–60.
- 11Fallah M, Liu X, Ji J et al. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol 2014; 25: 2025–30.
- 12Fallah M, Liu X, Ji J et al. Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype. Ann Oncol 2014; 25: 1397–404.
- 13Bald T, Quast T, Landsberg J et al. Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 2014; 507: 109–13.
- 14Daurkin I, Eruslanov E, Stoffs T et al. Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway. Cancer Res 2011; 71: 6400–9.
- 15Haq R, Shoag J, Andreu-Perez P et al. Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. Cancer Cell 2013; 23: 302–15.
